Article
Assessing the availability of Repurposed Orphan Drugs in India
2022-12-26
Abstract excerpt
India has a massive burden of rare diseases (RDs), estimated to be around 96 million living patients but limited options for treatment. Drugs used for RDs are known as Orphan Drugs. Globally, 95% of RDs do not have an approved drug for treatment. Novel orphan drugs are characteristically expensive and out of reach for most Indian patients. Repurposing drugs used for other common conditions have been considered an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9785ae98-41b1-589e-94ef-bf21575b989b
- DOI
- 10.1101/2022.12.22.22283870
